Replies to post #20564 on Innovus Pharmaceuticals Inc. (fka INNV)

[ShawnP123]

RH- This will end up below 0.35 after the merger and here's why:

Either just before or after the merger, at least 20M more shares of AYTU will be issued. They will need a reverse split to float more shares without crushing the stock. After the reverse split there will most likely be a name change (that is a tactic Dr. Da uses). The stock will drop at least 50% after the RS. Don't forget neither AYTU nor INNV make any money and burn through case (paying out unjustified salaries. If Randy is part of the deal, I believe his pay out is $750K.

So in the mid to long run, you would lose money even at 0.35.

[gi197845]

Hi, in my opinion, having been invested in Innovus for four years, having read all posts, having read all articles, I would stay 100% the hell away from this scam Innovus, nor would I buy any of their snake-oil products.

In my opinion, the only way you might be able to make some money, is at some point after the merger, shorting the stock, which I don't recommend.

My problem, was that I invested first, after the hype and listened to the pumpers, before I did my due diligence/research.

I should have listed to my gut, when I thought the products were snake-oil and when I heard Dr.Damaj's fake enthusiasm on the conference call, where he literally sounded like a fast talking, hill-billy auctioneer...The fast talking/fake enthusiasm was to con people and get their emotions up.

Any article that states Damaj got the stock price up, anywhere at anytime, does not admit that it was due to a reverse split.

Stay the F out of Innovus.

There is a 1 in a million chance that you could make a dollar back.

If you want biotech, look at these...

ACAD, ATRS and LPCN. Lipocene just failed FDA approval a second or third time, but should get approval next submission for the Testosterone increase pill, which has a few applications/benefits. The share price for LPCN is down, but should only go up from here.

ACAD and ATRS are both on their way up and the only thing that I think might go bad for biotech's in general is if the republicans and democrats start talking about price gouging and going after big pharma.